Paul Von Hoegen
Senior Director and Managing Director Euraccine
Life science
Ad Environmental Services LLC
Belgium
Biography
Dr. Paul von Hoegen is a Senior Consultant and Managing Director Euraccine after his time as Senior Director at JPT Peptide Tecnologies and at The Weinberg Group. He has key expertise is in the life science sector and pharmaceutical research and development. He supports clients in the pharmaceutical, food and consumer products industries as they seek to develop and manage strategies to optimize their relations with the biotechnology industry, in addition to maintaining their existing business. He also assists clients in critical analysis and design of pre-clinical biocompatibility and efficiency studies, design of clinical protocols, and management of client-sponsored contract research. Previously, Dr. von Hoegen worked at GlaxoSmithKline Biologicals on the pre-clinical and clinical development of new innovative vaccines for viral diseases. He was part of the strategic team that explored new therapeutic approaches for cancer, HIV, hepatitis and HPV.
Research Interest
Specialties: Immunotherapy including vaccines for infectious disease and cancer. Genetherapy and drug delivery. Preclinical to early clinical development. Scientific Leader for a large epidemiological cancer study. Identification and management of CRO's and sites (site whisperer). Study rescue and biomarker selection.
